LOGO
LOGO

Quick Facts

ChinaEdu Q3 Profit Down - Quick Facts

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

ChinaEdu Corp. (CEDU) reported third-quarter net income attributable to the company of $0.5 million compared to $0.9 million in the same period last year.

Net income attributable to the company per ADS was $0.030 for the third quarter of 2012, compared to $0.057 for the corresponding period in 2011.

Adjusted net income attributable to the company was $1.9 million in the third quarter of 2012 compared to $1.4 million in the corresponding period of 2011.

Adjusted net income attributable to the company per ADS was $0.115, for the third quarter of 2012, compared to $0.083 last year.

Total net revenue for the third quarter of 2012 was $19.7 million, a 8.7 percent increase from $18.1 million in the comparable quarter last year.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.11 per share on revenues of $19.07 million for the quarter. Analysts' estimates typically exclude special items.

ChinaEdu expects total net revenue in the fourth quarter of 2012 to range from RMB124 million to RMB129 million or $19.7 million to $20.5 million, representing a three percent to seven percent increase compared to the corresponding period in 2011.

Analysts expect the company to report revenues of $19.90 million for the fourth-quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19